Evidence map›Paper›PMID 42656749›Full record

ArticleFrontiers in aging neuroscience2026

Dual-task gait and gait-cognition coupling in patients with Parkinson's disease versus healthy older adults: moderation by cognitive status.

Bora Jin, Sang-Myung Cheon

Abstract read
In one paragraph

Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bora JinDepartment of Neurology, College of Medicine, Dong-A University, Busan, Republic of Korea.
Sang-Myung CheonDepartment of Neurology, College of Medicine, Dong-A University, Busan, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Gait impairment and cognitive decline frequently co-occur in Parkinson's disease (PD), yet how cognitive status modulates dual-task gait-cognition relationships remains poorly characterized. Objective: To compare spatiotemporal gait parameters and dual-task costs (DTCs) between drug-naïve PD and healthy older adults (HO), and to examine how cognitive status modulates gait-cognition associations within PD. Methods: One hundred twenty-four participants (65 PD, 59 HO) were prospectively enrolled. PD patients were subclassified into cognitively normal (PDCN, Results: PD-related gait impairments were more pronounced under dual-task conditions, with cell phone use yielding the greatest between-group differences in spatiotemporal parameters and DTCs. Gait-cognition associations in the total PD group were most consistently observed during cell phone use, involving executive, language, and attention domains. DTCs were specifically correlated with executive and language domains. Subgroup analyses revealed distinct cognitive-motor profiles: PDCN showed a paradoxical pattern in which better visuospatial function was associated with greater gait variability, while PDMCI exhibited broader positive correlations between multiple cognitive domains and gait stability. Moderation analyses confirmed these patterns were statistically distinct. Conclusion: Dual-task gait assessment using a cell phone paradigm may effectively characterizes cognitive-motor decline in early drug-naïve PD. Cognitive status qualitatively modulates gait-cognition coupling, with domain-specific patterns differing between PDCN and PDMCI, with implications for targeted monitoring and intervention.

Indexed as

cognitive-motor associationsdual-task gaitgait analysismild cognitive impairmentParkinson’s disease

Identifiers

PMID42656749
PMCPMC13506864

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.